£0.5 million for UK cancer-depression correlation study:
This article was originally published in Clinica
Cancer Research UK has provided £500,000 ($0.8m) to the University of Edinburgh to research the correlation between cancer and depression. A three-year study, led by Dr Michael Sharpe, in co-operation with the CRUK centre at Edinburgh's Western General Hospital, will seek to devise a care strategy that better accounts for the psychological problems that aggravate the effects of cancer and its treatment. Some 10% of the 5,000 patients who each year begin treatment at the hospital's oncology unit will suffer from depression.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.